Role of human challenge trials (HCTs) in drug development for respiratory syncytial virus (RSV)
Prosenjit Kundu, Mark Quinn, Jared C. Christensen, Elaine Thomas, Sima S. Toussi, Negar Niki Alami, Anindita Banerjee
doi: https://doi.org/10.1101/2024.05.24.24307680
Prosenjit Kundu
1Pfizer Inc., Cambridge, MA, USA
PhDMark Quinn
2USA Pfizer Ltd, London, UK
MPHJared C. Christensen
1Pfizer Inc., Cambridge, MA, USA
PhDElaine Thomas
2USA Pfizer Ltd, London, UK
PhDSima S. Toussi
3Pfizer Inc., New York, NY
MDNegar Niki Alami
3Pfizer Inc., New York, NY
MDAnindita Banerjee
1Pfizer Inc., Cambridge, MA, USA
PhDArticle usage
Posted May 24, 2024.
Role of human challenge trials (HCTs) in drug development for respiratory syncytial virus (RSV)
Prosenjit Kundu, Mark Quinn, Jared C. Christensen, Elaine Thomas, Sima S. Toussi, Negar Niki Alami, Anindita Banerjee
medRxiv 2024.05.24.24307680; doi: https://doi.org/10.1101/2024.05.24.24307680
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)